Stratton Management’s AbbVie ABBV Stock Holding History

Stratton Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$17M	Sell	287,698 -32,624	-10%	-$1.88M	2.07%	2
2015 Q3	$17.4M	Buy	320,322 +69,151	+28%	+$4.5M	2%	2
2015 Q2	$16.9M	Sell	251,171 -24,380	-9%	-$1.59M	0.74%	49
2015 Q1	$16.1M	Buy	275,551 +62,015	+29%	+$3.75M	0.66%	55
2014 Q4	$14M	Buy	213,536 +21,545	+11%	+$1.36M	0.58%	68
2014 Q3	$11.1M	Sell	191,991 -20,879	-10%	-$1.16M	0.5%	75
2014 Q2	$12M	Buy	212,870 +3,066	+1%	+$161K	0.5%	75
2014 Q1	$10.8M	Buy	209,804 +3,361	+2%	+$170K	0.5%	73
2013 Q4	$10.9M	Buy	206,443 +265	+0.1%	+$13K	0.52%	71
2013 Q3	$9.22M	Buy	206,178 +15,907	+8%	+$705K	0.48%	79
2013 Q2	$7.87M	Buy	+190,271	New	+$8.32M	0.46%	84

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stratton Management's ABBV Position: Q4 2015 in Review

Stratton Management reduced its AbbVie (ABBV) stake by 10% in Q4 2015, selling an estimated $1.88M and leaving 287,698 shares worth $17M. The position accounts for 2.07% of the portfolio, ranked #2.

Stratton Management first reported a position in ABBV in Q2 2013 and has held it in 11 quarters since. The position peaked at $17.4M in Q3 2015. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Stratton Management held 287,698 shares of AbbVie worth $17M as of Q4 2015.
Stratton Management sold 32,624 AbbVie shares in Q4 2015, an estimated $1.88M.
AbbVie made up 2.07% of Stratton Management's portfolio in Q4 2015, its #2 holding.
Stratton Management first reported a position in AbbVie in Q2 2013 and has held it in 11 quarters since.
Stratton Management's AbbVie position peaked at $17.4M in Q3 2015.
1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.